Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant

Study limitation reported by the research below: “No adjustment for multiple comparisons was applied across the numerous subgroup analyses; borderline p-values should be interpreted with caution.”